MoneyWorks4Me

Kotak Mahindra Mutual Fund buys stake worth Rs 612 crore in Emcure Pharmaceuticals

10 Jun 2026 Evaluate

Kotak Mahindra Mutual Fund has acquired stake in Emcure Pharmaceuticals from BC INVESTMENTS IV, the private equity investment holding company owned by Bain Capital, through an open market transaction worth Rs 612 crore. Kotak Mahindra Mutual Fund has bought 36 lakh equity shares, representing 1.89% of total share holding, of the company at price of Rs 1,700 apiece. 

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..